Sleep Medications Market Size & Share 2024 to 2032
Market Size by Type (Prescription-based, OTC), Drug Class (Benzodiazepines, Antidepressants, Antihistamines), Sleep Disorder Type.
Report ID: GMI6681
|
Published Date: September 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Sleep Medications Market Size
Sleep Medications Market size was valued to be USD 21.5 billion in 2023 and is predicted to experience a sustainable development of CAGR 6.8% by 2032, due to changed and stressful lifestyle of people. Furthermore, the innovative product offerings and technological advancements in the sleep tech devices.
Sleep Medications Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Sleep medications encompass a range of substances and pharmaceuticals specifically formulated to assist individuals in enhancing the quality and duration of their sleep, ultimately improving their overall sleep experience. These medications are employed to address a variety of sleep-related issues, including difficulties with falling asleep (commonly known as insomnia), staying asleep, or achieving a restful and rejuvenating sleep. The primary objective of sleep medications is to encourage healthier sleep patterns, alleviate disruptions in sleep, and contribute to an overall sense of well-being by facilitating more restorative and satisfying sleep.
COVID-19 Impact
The COVID-19 pandemic majorly impacted the sleep medications industry and resulted in an increase in the revenue of the market. Stress and anxiety increased due to the pandemic led to sleep deprivation and daytime fatigue, thereby fostered demand of sleep medications. Additionally, longer shifts that required workers to change their sleep cycles presented another issue for certain frontline workers and medical personnel. For instance, as per the article published by the Sleep Foundation Organization in March 2022, COVID-19 has altered and interrupted sleep patterns in a variety of ways, according to medical professionals and sleep scientists over the last two years. In addition, social exclusion, remote education, and limitations on daily activities caused depression among patients, that increased their risk of sleep problems such as insomnia and led to an increase in usage of sleep medications.
Sleep Medications Market Driving Factors
The increasing prevalence of sleep disorders is a major factor that has surged the expansion of the industry. For instance, according to an NCBI article published in December 2021, sleep disorders that last a month or longer are common among the people of Japan, accounting for about 20% of the population. Additionally, in Japan, the economic cost of sleep problems, such as insomnia, is estimated to be around USD 3 billion. Moreover, according to the NIH study published in August 2021, chronic insomnia is the most common sleep problem in Australia, affecting 12.2% of adults.
Sleep Medications Market Restraining Factors
The side effects associated with the use of sleep medications are expected to hamper the gains of the industry. For instance, according to report by World Health Organisation (WHO), the side effects associated with the use sleep medications are, irregular menstrual bleeding patterns and amenorrhea (the absence of menstrual bleeding). Additionally, other than menstrual disruption, some other side effects were also observed in women such as, weight gain, heavier menstrual bleeding, headaches, dizziness, body aches, nervousness, fatigue, and acne. Similarly, side effects such as constipation, dry mouth, and muscle weakness are observed in men. These side effects are somehow making people less interested towards the use of sleep medications.
Sleep Medications Market Analysis
Based on type, the sleep medications market is segmented into prescription-based drugs and OTC drugs. In 2022, the prescription-based drugs segment accounted for the largest market share of 71.3% in the industry and is expected to grow at a CAGR of 6.7% by 2032. Prescription-based drugs are favored for several reasons, including their targeted effectiveness and the healthcare professionals' capacity to customize treatment to address an individual's unique sleep disorder. These prescription medications are typically more potent and can effectively manage intricate sleep disorders, offering dependable relief for individuals enduring severe or chronic sleep problems. Furthermore, the oversight and monitoring provided by healthcare providers guarantee the safe and suitable utilization of these drugs.
Based on drug class, the sleep medications market is segmented into benzodiazepines, antidepressants, antihistamine, sedating antipsychotics, and other drug class. The benzodiazepines drug class is expected to showcase progress at a CAGR of 6.2% by 2032, Benzodiazepines exert their effects by enhancing the activity of neurotransmitters and induce drowsiness, reducing the time it takes to fall asleep, and extend the duration of sleep. Additionally, the ability of benzodiazepines to promote relaxation and sedation, makes this drug class more useful for individuals suffering from acute or severe sleep disorders such as insomnia or anxiety-related sleep disturbances.
Based on sleep disorder type, the sleep medications market is segmented into insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleep walking, and other sleep disorders. The sleep disorder insomnia held the largest market share of 38.7% in 2022 and is expected to grow at a CAGR of 5.8% by 2032. For instance, as per the article published by Sleep Doctor Holdings, LLC, in 2023, 50-70 million U.S. citizens are affected by insomnia every year and nearly half of the population of the U.S. have experienced insomnia symptoms at some time. Additionally, the report also stated that 237 million people globally are struggling with insomnia.
Based on the region, In 2022, North America sleep medications market accounted for a revenue of USD 8.3 billion, and it is expected to reach USD 15.3 billion by 2032 attributed to factors such as the fast-paced and high-stress lifestyles that many individuals lead. The demands of busy work schedules, lengthy commutes, and the presence of societal stressors such as economic pressures and competitive work environments can all contribute to sleep disturbances and insomnia. Additionally, the occurrence of key business companies in the U.S. with the growing consumer awareness associated with the products of sleep medications and sleep excellence.
Sleep Medications Market Share
The prominent players in sleep medications market include:
Sleep Medications Industry News:
The sleep medications market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Type
By Drug Class
By Sleep Disorder Type
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →